OMEROS CORP License Agreements
10 Contracts & Agreements
- Amendment No. 2 to License Agreement with an effective date of January 25, 2013 between Omeros Corporation and Daiichi Sankyo Co., Ltd (Filed With SEC on April 1, 2024)
- Amendment No. 1 to License Agreement with an effective date of January 5, 2011 between Omeros Corporation and Daiichi Sankyo Co., Ltd (Filed With SEC on April 1, 2024)
- License Agreement between Omeros Corporation and Daiichi Sankyo Co., Ltd. (successor-in-interest to Asubio Pharma Co., Ltd.) dated March 3, 2010 (Filed With SEC on April 1, 2024)
- Technology License Agreement, effective August 28, 2020 between Omeros Corporation and Xencor, Inc (Filed With SEC on March 13, 2023)
- LICENSE AGREEMENT (Filed With SEC on August 10, 2015)
- Amendment No. 2 to LICENSE AGREEMENT (Filed With SEC on May 9, 2013)
- Amendment No. 2 to LICENSE AGREEMENT (Filed With SEC on March 18, 2013)
- Amendment No. 1 to LICENSE AGREEMENT (Filed With SEC on May 10, 2011)
- EXCLUSIVE LICENSE AND SPONSORED RESEARCH AGREEMENT between OMEROS CORPORATION and MEDICAL RESEARCH COUNCIL (Filed With SEC on May 15, 2009)
- EXCLUSIVE LICENSE AND SPONSORED RESEARCH AGREEMENT (Filed With SEC on May 15, 2009)
